LogiPharma USA 2025: The Conference's Development Over 20 Years

At the 20th anniversary of LogiPharma USA, Dave Malenfant reflected on the event’s growth and its pivotal role in shaping discussions across the pharmaceutical supply chain. With over 700 attendees and standing-room-only master classes, Malenfant emphasized the strong industry engagement and the event’s ability to attract professionals from diverse company sizes and both clinical and commercial supply chain functions.

Looking back over two decades, Malenfant pointed out how the industry and the conference itself have evolved. In the early years, the sector was heavily male dominated, but today, greater female representation is evident across attendees and leadership roles. He credited Logipharma for broadening its reach and relevance, adapting to trends, and becoming, in his view, the premier global conference for pharmaceutical supply chain leaders.

For Malenfant, the continued growth of Logipharma is a testament to its ability to remain timely and relevant, bringing together a community that is both tackling current challenges and preparing for future transformations in supply chain management.

A transcript of Malenfant’s conversation with Pharmaceutical Commerce (PC) can be found below.

PC: With LogiPharma USA celebrating 20 years, how have you seen it develop over the years?

Malenfant: When LogiPharma first came out, there were not a lot of women, and it was a very male dominated industry. And we've evolved where, if you notice the crowd now, a lot of women. Finally, we've got a lot of women that are coming into the industry, WBR and LogiPharma has done a really good job of trying to embrace as many different companies, small, medium, large, and in folks that are really concentrated on both the clinical side and on the commercial side of supply chain. And I've seen it grow and then drop off because of Covid. And now this is by far the largest that they've had, and the subject matter the very relevant, the content in the on the agenda is always very relevant for the trends and for the happenings of the time that's coming up. So I think, you know, they've really evolved to becoming, in my opinion, the premier conference for the pharmaceutical industry.